Compare HALO & ESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | ESI |
|---|---|---|
| Founded | 1998 | 1922 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 10.5B |
| IPO Year | 2001 | 2014 |
| Metric | HALO | ESI |
|---|---|---|
| Price | $71.61 | $39.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | ★ $78.64 | $35.56 |
| AVG Volume (30 Days) | 1.8M | ★ 2.7M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.75% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.22 | 0.23 |
| Revenue | $151,862,000.00 | ★ $2,551,200,000.00 |
| Revenue This Year | $28.24 | $21.24 |
| Revenue Next Year | $12.56 | $7.34 |
| P/E Ratio | ★ $58.69 | $183.00 |
| Revenue Growth | N/A | ★ 3.84 |
| 52 Week Low | $51.06 | $20.95 |
| 52 Week High | $82.22 | $45.52 |
| Indicator | HALO | ESI |
|---|---|---|
| Relative Strength Index (RSI) | 60.66 | 44.00 |
| Support Level | $67.94 | $38.16 |
| Resistance Level | $74.58 | $45.52 |
| Average True Range (ATR) | 2.03 | 1.39 |
| MACD | 0.27 | -0.32 |
| Stochastic Oscillator | 86.63 | 31.49 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Element Solutions Inc is a specialty chemicals company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. The company's reportable segments are Electronics and Industrial & Specialty. The Electronics segment, which generates maximum revenue, researches, formulates, and sells specialty chemicals and process technologies for all types of electronics hardware, from complex printed circuit board designs to semiconductor packaging. This segment's wet chemicals for metallization, surface treatments, and solderable finishes form the physical circuitry pathways, and its assembly materials, such as solder, pastes, fluxes, and adhesives, join those pathways together.